Tuesday, Oct 27, 2026
Focus on the big picture

Novavax CEO: Vaccine Trial Enrollment an 'Important Milestone'

Bloomberg, 01 Dec 2020
Nov.30 -- Novavax Chief Executive Officer Stan Erck updates the company's progress on development and commercial production of a Covid-19 vaccine.
Related Articles